Meanwhile, Eli Lilly, manufacturer of competing GLP-1s Mounjaro and Zepbound, is continuing to do pretty well
6 The discontinuation rates for tirzepatide-treated groups varied between the studies, with study 1 showing discontinuation rates of 14.3%, 16.4%, and 15.1% for the 5 mg, 10 mg, and 15 mg tirzepatide-treated groups, respectively, compared to 26.4% for the placebo-treated group
In This Article Understanding Autoimmune Conditions Limitations of Current Treatments How Does Peptide Therapy Work
Jessica Drummond 00:52:10 Right
As someone who treats these people regularly, I have personally seen the struggles that patients have in trying to lose weight, Cheng, who was likewise not involved in the review, told MNT
It tends to happen at the start of treatment and subsides within hours or days of beginning use